Cart is empty A study led by researchers from IGTP’s Immunology of Diabetes group has identified new microRNA as biomarkers for the partial remission phase, also known as “honeymoon phase,” of type 1 diabetes, and has linked the miR-30d-5p microRNA to immunoregulatory processes that may take place during this phase.
Leave A Comment